When comparing the two kidney nephropathy models, we propose that CBGA-induced inhibition of TRPM7 may progressively shift its impact on different target cell populations depending on the stage of progressive kidney damage: In the acute stage of nephropathy, the damage will mostly involve tubular epithelial cells, whereas the late stage will mainly involve progressive renal fibrosis. This evidence concerns the gene TRPM7 and kidney disorder.